Searchable abstracts of presentations at key conferences in endocrinology

ea0020p489 | Obesity and Metabolism | ECE2009

Effect of pharmaceutical intervention on serum levels of advanced glycated end products in women with polycystic ovary syndrome

Diamanti-Kandarakis Evanthia , Christakou Charikleia , Piperi Chistina , Kandaraki Eleni , Katsikis Ilias , Adamopoulos Christos , Papavasiliou Athanasios G , Panidis Dimitrios

Background: Polycystic ovary syndrome (PCOS) is associated with obesity and insulin resistance, two major contributors to cardiovascular risk. Even in the absence of detectable insulin resistance, lean, non-diabetic PCOS women demonstrate increased circulating levels of advanced glycated end products (AGEs), known proatherogenic molecules. This adverse cardiovascular risk profile should be considered in the syndrome’s management.Objective: To invest...

ea0016p170 | Comparative endocrinology | ECE2008

Serum levels of the soluble isoform of the receptor of advanced glycosylated end products (sRAGE) are increased in women with PCOS

Piperi Christina , Tantalaki Evangelia , Livadas Sarantis , Christakou Claire , Xirafis Xenophon , Adamopoulos Christos , Kandarakis Stelios , Papavassiliou Athanasios , Diamanti-Kandarakis Evanthia

Serum levels of soluble RAGE (sRAGE total), the soluble isoform of the receptor of advanced glycated end products (AGEs) that lacks the transmembrane and intracytoplasmic domains of RAGE, has been found elevated in type 2 diabetics and non diabetic subjects and positively correlated with AGEs levels. In women with PCOS, while serum AGEs have been demonstrated to be elevated, sRAGE levels have not been determined as yet.The aim of the present study was to...

ea0056gp87 | Diabetes Epidemiology | ECE2018

Differential expression of apoptotic and low grade inflammatory markers in Alzheimer’s disease compared to diabetes mellitus type 1 and 2

Alexandraki Krystallenia , Apostolopoulos Nikolaos , Adamopoulos Christos , Stamouli Evangelia , Dalagiorgou Georgia , Papaioannou Theodoros , Analitis Antonios , Karamanou Marianna , Makrilakis Konstantinos , Politis Antonios , Piperi Christina

Objective: Neuroinflammation is a common primary or secondary mediator of the neurodegenerative process accompanying Alzheimer’s disease (AD). Impaired brain insulin signaling, defining brain insulin resistance may represent a link between AD and type 2 diabetes mellitus (T2DM) while neuronal apoptosis may also be involved in the inflammatory process. Peripheral cytokine levels of IL-1β, IL-6, TNFα along with high sensitivity C-reactive protein (hsCRP) and apopt...